Predictors of adverse surgical outcome in the management of malignant bowel obstruction
- PMID: 18807733
Predictors of adverse surgical outcome in the management of malignant bowel obstruction
Abstract
Introduction: Malignant bowel obstruction (MBO) is a common problem in patients with advanced colorectal or ovarian cancer. The management of this group of patients is complex and controversial.
Objective: To analyze the factors associated with morbidity and mortality in patients who underwent surgery for MBO in a tertiary referral center in Mexico City.
Material and methods: Hospital records of patients who underwent surgery for malignant bowel obstruction from January 1987 through December 2005 were retrospectively analyzed. Demographic data, clinical and surgical variables were recorded. Morbidity and mortality within 30-day of surgical procedure were registered. Factors associated with outcome were analyzed with the chi-square test. Survival curves were constructed with the Kaplan-Meier method.
Results: One-hundred and thirty patients were included. Primary neoplasm was the cause of bowel obstruction in 51 (39.2%) patients. Resection and anastomosis was performed in 45 patients (34.6%); in 30 cases (23.1%) a palliative estoma was constructed. Hospital mortality rate was 10.8%, and major postoperative morbidity was 16.2%. Factors associated with a significant increase in surgical mortality were: advanced patient age 17.2% (p = 0.009), hipoalbuminemia 14.45% (p = 0.027) and surgery performed for neoplasms different from those of gastrointestinal origin 17.6% (p = 0.005). Surgical morbidity was significantly higher in patients with poor performance status 16.2% (p = 0.017), advanced age 18% (p = 0.04), and low albumin levels 13.5% (p = 0.03). Median survival for the entire cohort was nine months (95% CI 5-13). Actuarial one, three and five year survival were 38.4, 27.5 and 25.4%, respectively. The most significant predictor of survival was performance status.
Conclusions: When surgical management of MBO is considered, a careful assessment of the factors shown here to predict an adverse surgical outcome and poor prognosis is required.
Similar articles
-
Surgery as a bridge to palliative chemotherapy in patients with malignant bowel obstruction from colorectal cancer.Ann Surg Oncol. 2007 Apr;14(4):1264-71. doi: 10.1245/s10434-006-9303-6. Epub 2007 Jan 18. Ann Surg Oncol. 2007. PMID: 17235711
-
Outcomes of emergency surgical treatment in malignant bowel obstructions.Hepatogastroenterology. 2005 Jul-Aug;52(64):1122-7. Hepatogastroenterology. 2005. PMID: 16001644
-
Reoperation for palliation of recurrent malignant bowel obstruction in ovarian carcinoma.Gynecol Oncol. 2004 Oct;95(1):193-5. doi: 10.1016/j.ygyno.2004.07.028. Gynecol Oncol. 2004. PMID: 15385131
-
[Intestinal occlusion in cancer].Rev Gastroenterol Mex. 2004 Nov;69 Suppl 3:100-5. Rev Gastroenterol Mex. 2004. PMID: 16881208 Review. Spanish.
-
Surgical approaches to malignant bowel obstruction.J Support Oncol. 2008 Mar;6(3):105-13. J Support Oncol. 2008. PMID: 18402300 Review.
Cited by
-
Palliative surgery versus medical management for bowel obstruction in ovarian cancer.Cochrane Database Syst Rev. 2010 Jul 7;2010(7):CD007792. doi: 10.1002/14651858.CD007792.pub2. Cochrane Database Syst Rev. 2010. PMID: 20614464 Free PMC article.
-
Intestinal obstruction: predictor of poor prognosis in colorectal carcinoma?Epidemiol Health. 2015 Mar 30;37:e2015017. doi: 10.4178/epih/e2015017. eCollection 2015. Epidemiol Health. 2015. PMID: 25868638 Free PMC article.
-
Palliative care in patients with ovarian cancer and bowel obstruction.Support Care Cancer. 2015 Nov;23(11):3157-63. doi: 10.1007/s00520-015-2694-9. Epub 2015 Mar 25. Support Care Cancer. 2015. PMID: 25805450
-
Outcomes of palliative bowel surgery for malignant bowel obstruction in patients with gynecological malignancy.Oncol Lett. 2012 Nov;4(5):883-888. doi: 10.3892/ol.2012.835. Epub 2012 Jul 30. Oncol Lett. 2012. PMID: 23162616 Free PMC article.
MeSH terms
LinkOut - more resources
Medical